Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice.
Frégeau G, Sarduy R, Elimam H, Esposito CL, Mellal K, Ménard L, Leitão da Graça SD, Proulx C, Zhang J, Febbraio M, Soto Y, Lubell WD, Ong H, Marleau S. Frégeau G, et al. Among authors: elimam h. Atherosclerosis. 2020 Aug;307:52-62. doi: 10.1016/j.atherosclerosis.2020.06.010. Epub 2020 Jul 6. Atherosclerosis. 2020. PMID: 32721647 Free article.
A Linear Fragment of Unacylated Ghrelin (UAG6-13) Protects Against Myocardial Ischemia/Reperfusion Injury in Mice in a Growth Hormone Secretagogue Receptor-Independent Manner.
Huynh DN, Elimam H, Bessi VL, Ménard L, Burelle Y, Granata R, Carpentier AC, Ong H, Marleau S. Huynh DN, et al. Among authors: elimam h. Front Endocrinol (Lausanne). 2019 Jan 11;9:798. doi: 10.3389/fendo.2018.00798. eCollection 2018. Front Endocrinol (Lausanne). 2019. PMID: 30692964 Free PMC article.
A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice.
Gauvin J, Frégeau G, Elimam H, Ménard L, Huynh D, Lê C, Ahsanullah A, Lubell WD, Ong H, Marleau S. Gauvin J, et al. Among authors: elimam h. Front Pharmacol. 2023 May 30;14:1204905. doi: 10.3389/fphar.2023.1204905. eCollection 2023. Front Pharmacol. 2023. PMID: 37332345 Free PMC article.
Complement-mediated cellular injury.
Takano T, Elimam H, Cybulsky AV. Takano T, et al. Among authors: elimam h. Semin Nephrol. 2013 Nov;33(6):586-601. doi: 10.1016/j.semnephrol.2013.08.009. Semin Nephrol. 2013. PMID: 24161043 Review.
30 results